Chinese consensus on the clinical application of hepatobiliary magnetic resonance imaging contrast agent: Gadoxetic acid disodium-Reference-Cited by-同舟云学术

Chinese consensus on the clinical application of hepatobiliary magnetic resonance imaging contrast agent: Gadoxetic acid disodium

Published:2019-02 Issue:2 Volume:20 Page:54-61
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:J Dig Dis

Author:

Rao Sheng Xiang¹,Wang Jin²,Wang Jian³,Jiang Xin Qing⁴,Long Li Ling⁵,Li Zi Ping⁶,Li Zhen Lin⁷,Shen Wen⁸,Zhao Xin Ming⁹,Hu Dao Yu¹⁰,Zhang Hui Mao¹¹,Zhang Lin³,Huan Yi¹²,Liang Chang Hong¹³,Song Bin⁷,Zeng Meng Su¹^ORCID

Affiliation:

1. Department of Radiology, Zhongshan Hospital Fudan University, and Shanghai Institute of Medical Imaging Shanghai China

2. Department of Radiology, The Third Affiliated Hospital Sun Yat‐Sen University Guangzhou Guangdong Province China

3. Department of Radiology, Southwest Hospital Third Military Medical University Chongqing China

4. Department of Radiology Guangzhou First People’s Hospital Guangzhou Guangdong Province China

5. Department of Radiology The First Affiliated Hospital of Guangxi Medical University Nanning Guangxi Zhuang Autonomous Region China

6. Department of Radiology, The First Affiliated Hospital Sun Yat‐Sen University Guangzhou Guangdong Province China

7. Department of Radiology, West China Hospital Sichuan University Chengdu Sichuan Province China

8. Department of Radiology Tianjin First Central Hospital Tianjin China

9. Department of Diagnostic Imaging Chinese Academy of Medical Sciences Cancer Hospital Beijing China

10. Department of Radiology, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei Province China

11. Department of Radiology The First Hospital of Jilin University Changchun Jilin Province China

12. Department of Radiology, Xijing Hospital Fourth Military Medical University Xi'an Shaanxi Province China

13. Department of Radiology Guangdong Provincial People's Hospital, Guanggong Academy of Medical Sciences Guangzhou Guangdong Province China

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1751-2980.12707

Reference75 articles.

1. ChengKT. Gadoxetate [Updated2008Apr 10]. In: Molecular imaging and contrast agent database (MICAD). Bethesda MD: National Center for Biotechnology Information US; 2004‐2013. Available athttp://www.ncbi.nlm.nih.gov/books/NBK23122/. Accessed 8 February 2019.

2. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma

3. Pharmacokinetics and Imaging Properties of Gd-EOB-DTPA in Patients With Hepatic and Renal Impairment

4. Primovist, Eovist: What to expect?

5. Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients: a multicenter, open-label, phase III study

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of the performance of hepatobiliary agents in depicting MRI features of microvascular infiltration in hepatocellular carcinoma;Abdominal Radiology;2024-06-02

2. A convenient and reproducible protocol for acquisition of the hepatocyte phase for liver function-impaired patients in gadoxetic acid disodium-enhanced magnetic resonance imaging;Quantitative Imaging in Medicine and Surgery;2024-02

3. Comparison of the Ability of Gadobenate Dimeglumine and Gadolinium Ethoxybenzyl Dimeglumine to Display the major Features for Noninvasively Diagnosing Hepatocellular Carcinoma According to the LI-RADS 2018v;Technology in Cancer Research & Treatment;2024-01

4. Optimization of hepatobiliary phase imaging in gadoxetic acid-enhanced magnetic resonance imaging: a narrative review;Quantitative Imaging in Medicine and Surgery;2023-03

5. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition);Liver Cancer;2023